Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-07-22

Clinical Trial Update: Light Therapy Device for Neonatal Intraventricular Hemorrhage Grade 3 and 4 [NA]

View source ↗

Summary

A clinical trial is evaluating a light therapy device for neonatal intraventricular hemorrhage (Grade 3-4) and associated hydrocephalus; enrollment is ongoing.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Light therapy device (neonatal)

Snippet

Sponsor: Rutgers, The State University of New Jersey | Conditions: Intraventricular Hemorrhage of Prematurity, Hydrocephalus | NA | Status: RECRUITING